Reports
Reports
Sale
The global craniomaxillofacial implants market size was valued at USD 2.3 billion in 2023, driven by increasing prevalence of facial injuries, trauma, and cranial defects across the globe. The market is expected to grow at a CAGR of 7.13% during the forecast period of 2024-2032, with the values likely to rise from USD 2.5 billion in 2024 to USD 4.3 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Craniomaxillofacial implants are medical devices designed to be used in surgical reconstruction of the skull, jaws, and face. They are commonly made of titanium, owing to its high durability, strength, and biocompatibility. However, with technical advancements, other biocompatible materials have also emerged in the market.
The craniomaxillofacial implants market demand is driven by the rising incidence of oral and oropharyngeal cancer where it is used to reconstruct affected bones and tissues after the surgical removal of tumours. In 2023, around 54,540 adults (39,290 men and 15,250 women) were expected to get diagnosed with oral and oropharyngeal cancers, making it the eighth most common cancer among men.
In addition, craniomaxillofacial implants are often applied in reconstructing facial fractures and injuries resulting from trauma such as accidents, assaults or falls. People born with congenital facial anomalies also undergo craniomaxillofacial surgery. The market is further driven by the rising focus on improving facial aesthetics, prevalence for minimally invasive techniques and the emphasis on manufacturing patient specific implants.
Rising Adoption of 3D Printing Facilities to Boost Craniomaxillofacial Implants Market Growth
In August 2023, Materialise , a 3D printing leader in personalised medical solutions, opened a new 3D printing facility to offer accurate and time saving surgical outcomes during surgery. The new facility in Michigan, United States, specialises in 3D printing of personalized titanium cranio-maxillofacial (CMF) implants, used for facial reconstructive surgeries. Such solutions are designed to facilitate surgeons with more accurate surgical outcomes and offer personalised care at a reasonable cost. This also indicates a rising trend of minimally invasive surgeries, aimed to minimize scarring, and accelerate recovery times for patients.
New Product Launches to Offer Improved Solutions to Patients
Craniomaxillofacial implants can be implanted in the body permanently or temporarily, and they can be withdrawn when no longer required. However, there has been significant emphasis using biomaterial to offer improved patient outcomes. The craniomaxillofacial implants market size is poised to grow with the advent of several new product launches. The Inion CPS™ and Inion CPS™ Baby Bioabsorbable Fixation System are some of the most recent bioabsorbable products containing a range of resorbable meshes, screws and plates in various sizes and shapes. Composed of natural compounds like L-lactic acid, glycolic acid, and trimethylene carbonate, the range of products is safer for clinical use as well. It is one of the few bioabsorbable alternatives comparable to the titanium in its scope of use.
Increasing Technical Advancements to Minimise the Risk of Infection
The craniomaxillofacial implants market value is driven by the increasing research into preventing medical device associated infections. The sudden outbreak of COVID-19 propelled the adoption of new technologies in order to minimize medical device associated infections. In October 2023, Zimmer Biomet and Bactiguard showcased their latest collaboration, a technology designed to reduce the risk of biofilm formation on the medical implants involved in craniomaxillofacial and thoracic applications. The new technology is based on galvanic effects created on the basis of fluid and an ultra-thin noble metal coating amalgamation which inhibits the risk of microbe adherence on the surface.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Material of Construction
Market Breakup by Property
Market Breakup by Application Site
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is anticipated to lead the global market, owing to the considerable rise in craniomaxillofacial surgeries in the United States, increasing healthcare expenditure, and growing sports injuries and injuries related to cranial and facial bones. The growth in this region can be attributed to the increasing number of road accident cases and resultant injuries, trauma cases, the growing number of hospitals, and the rising number of new-borns with facial deformities. Also, various government initiatives, such as establishing the American Society of Craniofacial Surgery (ASCFS) for creating awareness about CMF surgeries and their associated advantages, are likely to contribute significantly to the rising craniomaxillofacial implants market share of the region.
Europe is another significant market owing to its robust healthcare infrastructure and the presence of prominent academic and research institutions. To offer better solutions and address unmet needs of patients, the government and authorities aim at educating the healthcare staff with latest technical advancements in the medical domain. In February 2023, an Indo-German workshop, BIODENT, was organised to foster innovation in design and manufacturing of biomaterials and implants for dental, cranio-maxillofacial reconstruction, and bone regeneration. Such initiatives play a critical role in boosting the craniomaxillofacial implants market growth in the region.
The Asia Pacific region, on the other hand, is expected to witness the highest demand during the forecast period. The demand is likely to emerge due to the high prevalence of hereditary facial abnormalities, a large base of geriatric population, rising awareness of the use of dental and orthopaedic implants and improving healthcare infrastructure. The rising rate of road accidents per year in Asian countries is also projected to increase the demand for craniomaxillofacial implants.
In December 2023, Stryker announced their motive to acquire Serf SAS and executed a binding offer to Serf’s corporate parent Menix which market dental implants and equipment for craniomaxillofacial surgery. With this acquisition, the company aims at expanding their product portfolio and offer improved and customised solutions to the patients. The deal is expected to close in first quarter of 2024. The market has been witnessing multiple strategic mergers and acquisitions between prominent companies to enhance their distribution networks and tap into emerging markets.
The key features of the craniomaxillofacial implants market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Material of Construction |
|
Breakup by Property |
|
Breakup by Application Site |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Craniomaxillofacial Implants Market Overview
3.1 Global Craniomaxillofacial Implants Market Historical Value (2017-2023)
3.2 Global Craniomaxillofacial Implants Market Forecast Value (2024-2032)
4 Global Craniomaxillofacial Implants Market Landscape
4.1 Global Craniomaxillofacial Implants Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Craniomaxillofacial Implants Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Material of Construction
4.2.3 Analysis by Property
4.2.4 Analysis by Application Site
5 Global Craniomaxillofacial Implants Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Craniomaxillofacial Implants Market Segmentation
6.1 Global Craniomaxillofacial Implants Market by Type
6.1.1 Market Overview
6.1.2 Mid Face
6.1.3 Plates
6.1.4 Screws
6.1.5 Mandibular Orthognathic Implants
6.1.6 Neuro
6.1.7 Mesh
6.1.8 Bone Graft
6.1.9 Dural Repair
6.1.10 Others
6.2 Global Craniomaxillofacial Implants Market by Material of Construction
6.2.1 Market Overview
6.2.2 Calcium Phosphate Ceramics
6.2.3 Titanium
6.2.4 Alloys and Other Metals
6.2.5 Polymers or Biomaterials
6.2.6 Others
6.3 Global Craniomaxillofacial Implants Market by Property
6.3.1 Market Overview
6.3.2 Resorbable
6.3.3 Non-Resorbable
6.4 Global Craniomaxillofacial Implants Market by Application Site
6.4.1 Market Overview
6.4.2 Internal Fixators
6.4.3 External Fixators
6.5 Global Craniomaxillofacial Implants Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Craniomaxillofacial Implants Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Craniomaxillofacial Implants Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Craniomaxillofacial Implants Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Craniomaxillofacial Implants Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Craniomaxillofacial Implants Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Zimmer Biomet
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medartis AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 KLS Martin Group
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Depuy Synthes
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Osteomed
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Integra Life Sciences Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Calavera Surgical Design
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 B. Braun Melsungen AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 General Implants GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Rebstock Instruments GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BIOPORE Surgical Implants
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Poriferous
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Osteotec
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Johnson & Johnson Services, Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Anatomics Pty. Ltd.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Craniomaxillofacial Implants Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 2.3 billion in 2023, driven by rising prevalence of facial injuries, trauma, and cranial defects across the globe.
The market is anticipated to grow at a CAGR of 7.13% during the forecast period of 2024-2032, likely to reach a market value of USD 4.3 billion by 2032.
The market demand is driven by the growing sports injuries, rising number of new-borns with facial deformities, growing demand for minimally invasive (MI) facial reconstruction treatments, technological advancements, growing geriatric population, increasing consumer expenditures, rise in the prevalence rate of congenital facial deformities, and developing healthcare infrastructure.
The major market trend includes rising integration of 3D applications to offer improved and personalised solutions to the patients. In August 2023, Materialise opened a new 3D printing facility that specialises in 3D printing of personalized titanium cranio-maxillofacial (CMF) implants.
Based on types, the market is divided into mid face, plates, screws, mandibular orthognathic implants, neuro, mesh, bone graft, and dural repair, among others.
Calcium phosphate ceramics, titanium, alloys, and other metals, polymers, or biomaterials, among others are common materials of construction are available in the market.
It includes resorbable as well as non-resorbable.
It is divided into internal and external fixators.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Zimmer Biomet, Stryker, Medartis AG, KLS Martin Group, Depuy Synthes, Osteomed, Integra Life Sciences Corporation, Medtronic, Calavera Surgical Design, B. Braun Melsungen AG, General Implants GmbH, Rebstock Instruments GmbH, BIOPORE Surgical Implants, Poriferous, Johnson & Johnson Services, Inc., Anatomics Pty. Ltd. and Osteotec.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.